Pictet Asset Management (Switzerland)’s Amphastar Pharmaceuticals AMPH Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$294K	Buy	+5,116	New	+$227K	﹤0.01%	1517

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s AMPH Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) opened a new position in Amphastar Pharmaceuticals (AMPH) in Q2 2023: 5,116 shares worth $294K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings.

246 funds tracked by Wall St. Rank hold AMPH as of Q2 2023.

Pictet Asset Management (Switzerland) held 5,116 shares of Amphastar Pharmaceuticals worth $294K as of Q2 2023.
Amphastar Pharmaceuticals was a new Pictet Asset Management (Switzerland) position in Q2 2023.
Amphastar Pharmaceuticals made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1517 holding.
246 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.